A prospective study comparing side-firing KTP laser enucleation vs. bipolar transurethral resection of bladder tumor for small bladder tumors in an outpatient setting

Tripathi, Mahesh; Masood, Pirzada Faisal; Sood, Rajeev; Singla, Anurag; Khattar, Nikhil; Manasa, T; Singh, Rajpal

doi:10.5173/ceju.2021.0012.r1

Cited by 1 publication

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, with respect to the identification of detrusor muscle in specimen, it was rarely analyzed in the previous meta-analysis owing to the small number of trials in the past. Recently, many trials were published containing the pathological outcome [ 12 , 19 , 23 , 24 , 28 , 29 , 30 , 31 , 32 , 34 , 35 , 36 ], so in this meta-analysis, 13 trials were enrolled, and the results were significantly superior in the ERBT compared to CTURBT group, but the test for heterogeneity was significant ( p < 0.00001, I 2 = 88%). Although we had this amazing result, the explanation of the result should be cautious and conservative.…”

Section: Discussionmentioning

confidence: 99%

Comparison of Pathological Outcome and Recurrence Rate between En Bloc Transurethral Resection of Bladder Tumor and Conventional Transurethral Resection: A Meta-Analysis

Wang¹,

Lee²,

Wu³

et al. 2023

Cancers

View full text Add to dashboard Cite

Current treatment for non-muscle invasive bladder cancer (NMIBC) is the conventional transurethral resection of bladder tumor (CTURBT), but the en bloc transurethral resection of bladder tumor (ERBT) has been gaining more attraction in recent years considering better specimen integrity. Thus, we conducted this meta-analysis to compare the safety and efficacy of ERBT versus CTURBT. Trials were collected from an online database. The primary outcomes included identification of detrusor muscle in specimen, residual tumor, 3, 12, and 24-month recurrence rates and same-site recurrence rate. A total of 31 trials were included. The ERBT group had a higher rate of identification of detrusor muscle in specimens (p = 0.003) and lower residual tumor (p < 0.001). Other than that, lower rates of 3-month (p = 0.005) and 24-month recurrence rate (p < 0.001), same-site recurrence rate (p < 0.001) and complications were also observed. For perioperative outcomes, shorter hospitalization time (HT) (p < 0.001), and catheterization time (CT) (p < 0.001) were also revealed in the ERBT group. No significant difference was found in operative time (OT) (p = 0.93). The use of ERBT showed better pathological outcomes and fewer complications, so it could be considered a more effective treatment option for NMIBC.

show abstract